Skip to main content Help with accessibility Skip to main navigation

Shared care

When clinical, and therefore prescribing, responsibility for a patient is transferred from hospital to GP, it is of the utmost importance that the GP has full confidence to prescribe the necessary drugs. It is, therefore, essential that a transfer involving drug therapies with which GPs would not normally be familiar should not take place without full local agreement and the dissemination of sufficient information to individual GPs.
When a consultant considers a patient's condition is stable, he may seek the agreement of the GP concerned to share care. In proposing a shared care arrangement, a consultant may advise the general practitioner which medicine to prescribe. Where a new, or rarely prescribed, medicine is being recommended, its dosage and administration must be specified by the consultant so that the GP is properly informed and can monitor treatment and adjust the dose if necessary. In addition, when a treatment is not licensed for a particular indication, then full justification for the use of the drug should be given by the consultant to the GP.

Walford D. Responsibility for prescribing between hospitals and GPs
NHS Executive Circular. EL (91) 127, November 1991

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Documents

Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of ATOMOXETINE for ADHD in accordance with NICE NG87.

NHS Halton CCG for the treatment of adults only
NHS Knowsley CCG for the treatment of adults only
NHS St Helens CCG for the treatment of adults only
NHS Warrington CCG for the treatment of adults only
NHS Wirral CCG for the treatment of adults only

NHS South Sefton CCG, NHS Southport and Formby CCG Shared Care Framework for Atomoxetine for the treatment of ADHD in adults

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of ATOMOXETINE for ADHD in children under the care of Alder Hey Children’s
Hospital and Wirral University Teaching Hospitals Foundation Trust in accordance with NICE NG87.

Body System:
Date Added: 26 - Nov - 2020

 

Shared care frameworks for the treatment of ADHD.

Refer to the individual documents for CCG approvals.

Body System:
Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Date Added: 26 - Apr - 2018
Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of DEXAMFETAMINE for ADHD in accordance with NICE NG87.

NHS Halton CCG for the treatment of adults only
NHS Knowsley CCG for the treatment of adults only
NHS St Helens CCG for the treatment of adults only
NHS Warrington CCG for the treatment of adults only
NHS Wirral CCG for the treatment of adults only

NHS South Sefton CCG, NHS Southport and Formby CCG Shared Care Framework for DEXAMFETAMINE for the treatment of ADHD in adults

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of DEXAMFETAMINE for ADHD in children under the care of Alder Hey Children’s
Hospital and Wirral University Teaching Hospitals Foundation Trust in accordance with NICE NG87.

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of GUANFACINE for ADHD in accordance with NICE NG87.

NHS Halton CCG for the treatment of adults only
NHS Knowsley CCG for the treatment of adults only
NHS St Helens CCG for the treatment of adults only
NHS Warrington CCG for the treatment of adults only
NHS Wirral CCG for the treatment of adults only

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of GUANFACINE for ADHD in children under the care of Alder Hey Children’s
Hospital and Wirral University Teaching Hospitals Foundation Trust in accordance with NICE NG87.

Body System:
Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of LISDEXAMFETAMINE for ADHD in accordance with NICE NG87.

NHS Halton CCG for the treatment of adults only
NHS Knowsley CCG for the treatment of adults only
NHS St Helens CCG for the treatment of adults only
NHS Warrington CCG for the treatment of adults only
NHS Wirral CCG for the treatment of adults only

NHS South Sefton CCG, NHS Southport and Formby CCG Shared Care Framework for LISDEXAMFETAMINE for the treatment of ADHD in adults

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of GUANFACINE for ADHD in children under the care of Alder Hey Children’s
Hospital and Wirral University Teaching Hospitals Foundation Trust in accordance with NICE NG87.

Body System:
Date Added: 05 - Nov - 2018
Body System:
Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017. N.B. Mercaptopurine is not included in these 2017 guidelines, but monitoring requirements in this document are in line with those included for azathioprine.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of METHYLPHENIDATE for ADHD in accordance with NICE NG87.

NHS Halton CCG for the treatment of adults only
NHS Knowsley CCG for the treatment of adults only
NHS St Helens CCG for the treatment of adults only
NHS Warrington CCG for the treatment of adults only
NHS Wirral CCG for the treatment of adults only

NHS South Sefton CCG, NHS Southport and Formby CCG Shared Care Framework for METHYLPHENIDATE for the treatment of ADHD in adults

Body System:
Date Added: 27 - Jan - 2022

The Pan Mersey Area Prescribing Committee recommends the prescribing of METHYLPHENIDATE for ADHD in children under the care of Alder Hey Children’s
Hospital and Wirral University Teaching Hospitals Foundation Trust in accordance with NICE NG87.

Body System:
Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning

Purple
Date Added: 22 - Sep - 2021
Body System:
Date Added: 26 - Sep - 2017

Indications, dose adjustments and monitoring requirements for disease modifying drugs (DMDs) (licensed and unlicensed indications) included in this Framework are in line with national guidance published by the British Society for Rheumatology 2017.

Adapted for local use

St Helens and Knowsley Teaching Hospitals NHS Trust

Wirral Health and Care Commissioning